Discussion
pain, OLP [, OLP
ORAL LICHEN PLANUS, RECURRENCE, RECURRENT APHTHOUS STOMATITIS
PK Mankapure et al., undertook a study to better understand the demographics and clinical characteristics of OLP in 108 patients. The findings revealed that 87.9% of cases involved the buccal mucosa, with females making up 70.4% of those affected [Kia et al., assessed the comparative efficacy of triamcinolone and curcumin in OLP patients where the use of curcumin showed a significant response. However, few patients had a burning sensation, and few reported the undesirable yellow color of the drug [Najafi et al., in a placebo-controlled clinical trial, systemically treated recurrent aphthous stomatitis with 235 mg purslane, yielding favorable pain control outcomes and reduced recurrence. These results tout the antioxidant and anti-inflammatory efficacy of purslane [In a placebo-controlled study by Agha Hosseini et al., in 2010, oral lichen planus patients were treated with 235 mg capsules prepared from the ethanolic extract of purslane leaves, and the results showed better clinical improvement with no reported side effects making purslane a favorable, safer alternative for treating OLP [